Feeding trial shows enzyme-hydrolyzed marine protein enhances metabolism in Pacific white shrimp on reduced fishmeal diets, suggesting improved feed sustainability.
An 8-weeks feeding trial was conducted to evaluate the effect of dietary enzyme-hydrolyzed marine protein (EMP) supplementation on appetite, protein and lipid metabolism of Litopenaeus vannamei fed reduced fishmeal diets. The control group was supplemented with 30 % fishmeal, in the experimental group, 28 % fish meal was supplemented with 1 % EMP (1 % EMP), and 26 % fish meal with 2 % EMP (2 % EMP). The results showed that there were no significant differences in growth performance in each group ( P > 0.05). Shrimp in control group exhibited higher total cholesterol, triglyceride and low-density lipoprotein cholesterol in hemolymph than those in the other groups ( P < 0.05). The results of intestinal histology showed that shrimp fed with 1 % EMP diet exhibited higher fold height and fold width than those fed the other diets ( P < 0.001). Compared with control group, the lipid catabolism genes and regulatory factors ( atgl, hsl, ampkα , ampkγ , acox1 ) was significantly enhanced in 1 % EMP group ( P < 0.05). Moreover, the neurotransmitter and appetite related-genes expressions (such as oa-ta , tdc , tbh and ghs-r1 ) in 1 % EMP group of cerebral ganglion were significantly up-regulated than those in other group ( P < 0.05). Dietary 1 % EMP supplementation activated expressions of TORC1 pathway-related genes ( tor , rheb , slc3a2 , 4e-bp ) in the hepatopancreas than those feed the control diet ( P < 0.05). In conclusion, the results revealed that reducing 2 % fish meal and adding 1 % EMP in the diet could improve the appetite, lipid and protein metabolism, intestinal and hepatopancreas health of juvenile Pacific white shrimp.
No takes yet. Share an insight, caveat, or question.
Li et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: